Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Professor Irina Udalova on her successful Wellcome Trust Investigator Award entitled “Molecular control of pathogenic neutrophil responses in inflammation”.

Irina has been awarded £1.5 million over 5 years to research how neutrophil function in the tissue is guided by intrinsic molecular regulators and influenced by extrinsic protein and lipid signals produced by macrophages. Recent work has highlighted a number of factors that will be functionally validated and the hypothesis that neutrophil accumulation and activity in tissues during sterile inflammation is controlled by resident and effector macrophages will be examined. Understanding the control of pathogenic neutrophil responses and identification of key regulators will help to redefine these understudied cells in chronic inflammatory disorders such as such as rheumatoid arthritis, atherosclerosis, diabetes  amongst others and may lead to new treatments reducing the burden of human chronic inflammatory disease.

Speaking of the award, Professor Udalova stated “I am delighted to receive this award as the recognition of our unique expertise in neutrophil genomics, recently developed cutting edge technologies and established key strategic collaborations. I believe our work in this extremely interesting and completely under-studied area of research in neutrophil biology will lead to important and transforming discoveries”.

The grant will start on the 1st February 2018.

Similar stories

New guidelines to improve reporting standards of studies that investigate causal mechanisms

Researchers at NDORMS have developed a new set of guidelines for reporting mediation analyses in health research.

New Associate Professors announced at NDORMS

The Medical Sciences Division has awarded the title of Associate Professor to five senior researchers at NDORMS.

COVID-19 vaccines shown to reduce infection by 90% in nursing homes

A new collaborative study between the Catalan Institute of Health, the Public Health Secreatariat of Catalonia, and the Centre for Statistics in Medicine, NDORMS, at the University of Oxford have confirmed that COVID-19 vaccines greatly reduce infections, hospitalisations and mortality for up to 6 months.

The Kennedy Institute completes its roof extension

Building work at the Kennedy Institute of Rheumatology has finished, providing a new third floor that houses additional meeting and collaboration space for data science and offices for the management of clinical trials.

Unlocking the secrets of the microbiome

Jethro Johnson, Deputy Director of the Oxford Centre for Microbiome Research explains how the centre is building a research community to understand the microbiome and harness its power to promote health and prevent disease.

Into the future: watching biology unfold

As part of the University of Oxford’s mission to provide its researchers with the newest state-of-the-art optical imaging equipment and as part of a strategic partnership with the Kennedy Institute of Rheumatology (KIR), the Institute of Developmental and Regenerative Medicine (IDRM), and Carl Zeiss AG (ZEISS), ZEISS has installed a ZEISS Lattice Lightsheet 7 microscope at the KIR.